Accelerate Blue Fund
The Accelerate Blue Fund (ABF) is an early stage venture fund that exclusively invests in University of Michigan (U-M) licensed startups.
Frankel Innovation Initiative
The Frankel Innovation Initiative is a $20 million fund supporting the research and development of life-saving therapies at Michigan Medicine.
Great Lakes Discovery
Great Lakes Discovery, a venture launched by Deerfield Management Company, will invest up to $130M over the next decade in biomedical research at U-M with the aim of developing potentially life-saving drugs and disease treatments.
Michigan Biomedical Venture Fund
The Michigan Biomedical Venture Fund (MBVF) invests in biomedical startup companies with U-M licensed IP in the domain of therapeutics, devices, diagnostics, or health IT.
Michigan Drug Discovery
Supporting and facilitating drug discovery programs led by faculty at the University of Michigan.
Michigan Life Science and Innovation Center (MLSIC)
The goal of MLSIC is to catalyze growth by combining state-of-the-art laboratory space and entrepreneurial support in one location. Through daily contact with leaders in the life science industry, start-ups gain the advantage of on-site mentoring and ready access to expertise in finance, business development, marketing, sales, HR, and logistics.
Michigan Institute for Clinical & Health Research
The Michigan Institute for Clinical & Health Research (MICHR) is here to enable & enhance clinical & translational research at U-M. We do this by being a catalytic partner that educates, funds, connects & supports research teams here and beyond. Think of our helpful and knowledgeable staff and faculty as your extended research team.
MTRAC Innovation Hub for Life Sciences
The Michigan Translational Research and Commercialization for Life Sciences Innovation Hub is a statewide program supporting translational research projects in life sciences with high commercial potential, with the ultimate goal of positively impacting human health.